Company Info
Phone(585) 271-2700
Year Established
1997
Ticker
VCNX
Exchange
Nasdaq
Contacts
John E. Leonard, Ph.D.Senior VP, Development & Officer
Company Description
Vaccinex is pioneering a differentiated approach to treating neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D), a key driver of neuroinflammation.
